539 related articles for article (PubMed ID: 34683943)
1. CRISPR/Cas9 Delivery System Engineering for Genome Editing in Therapeutic Applications.
Cheng H; Zhang F; Ding Y
Pharmaceutics; 2021 Oct; 13(10):. PubMed ID: 34683943
[TBL] [Abstract][Full Text] [Related]
2. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
3. CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery.
Wang HX; Li M; Lee CM; Chakraborty S; Kim HW; Bao G; Leong KW
Chem Rev; 2017 Aug; 117(15):9874-9906. PubMed ID: 28640612
[TBL] [Abstract][Full Text] [Related]
4. Two Distinct Approaches for CRISPR-Cas9-Mediated Gene Editing in Cryptococcus neoformans and Related Species.
Wang P
mSphere; 2018 Jun; 3(3):. PubMed ID: 29898980
[No Abstract] [Full Text] [Related]
5. Different Methods of Delivering CRISPR/Cas9 Into Cells.
Chandrasekaran AP; Song M; Kim KS; Ramakrishna S
Prog Mol Biol Transl Sci; 2018; 159():157-176. PubMed ID: 30340786
[TBL] [Abstract][Full Text] [Related]
6. Non-viral delivery systems for CRISPR/Cas9-based genome editing: Challenges and opportunities.
Li L; Hu S; Chen X
Biomaterials; 2018 Jul; 171():207-218. PubMed ID: 29704747
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in the delivery and applications of nonviral CRISPR/Cas9 gene editing.
Sinclair F; Begum AA; Dai CC; Toth I; Moyle PM
Drug Deliv Transl Res; 2023 May; 13(5):1500-1519. PubMed ID: 36988873
[TBL] [Abstract][Full Text] [Related]
8. Engineering nucleic acid chemistry for precise and controllable CRISPR/Cas9 genome editing.
Cai W; Wang M
Sci Bull (Beijing); 2019 Dec; 64(24):1841-1849. PubMed ID: 36659580
[TBL] [Abstract][Full Text] [Related]
9. Lipid nanoparticles: The game-changer in CRISPR-Cas9 genome editing.
Mohammadian Farsani A; Mokhtari N; Nooraei S; Bahrulolum H; Akbari A; Farsani ZM; Khatami S; Ebadi MS; Ahmadian G
Heliyon; 2024 Jan; 10(2):e24606. PubMed ID: 38288017
[TBL] [Abstract][Full Text] [Related]
10. CRISPR/Cas9 systems: Delivery technologies and biomedical applications.
Du Y; Liu Y; Hu J; Peng X; Liu Z
Asian J Pharm Sci; 2023 Nov; 18(6):100854. PubMed ID: 38089835
[TBL] [Abstract][Full Text] [Related]
11. Delivery of CRISPR/Cas9 for therapeutic genome editing.
Xu X; Wan T; Xin H; Li D; Pan H; Wu J; Ping Y
J Gene Med; 2019 Jul; 21(7):e3107. PubMed ID: 31237055
[TBL] [Abstract][Full Text] [Related]
12. Engineered CRISPR Systems for Next Generation Gene Therapies.
Pineda M; Moghadam F; Ebrahimkhani MR; Kiani S
ACS Synth Biol; 2017 Sep; 6(9):1614-1626. PubMed ID: 28558198
[TBL] [Abstract][Full Text] [Related]
13. Recent Advances in Genome Editing Using CRISPR/Cas9.
Ding Y; Li H; Chen LL; Xie K
Front Plant Sci; 2016; 7():703. PubMed ID: 27252719
[TBL] [Abstract][Full Text] [Related]
14. Development of CRISPR/Cas Delivery Systems for In Vivo Precision Genome Editing.
Chen Y; Ping Y
Acc Chem Res; 2023 Aug; 56(16):2185-2196. PubMed ID: 37525893
[TBL] [Abstract][Full Text] [Related]
15. Clinical applications of the CRISPR/Cas9 genome-editing system: Delivery options and challenges in precision medicine.
Khoshandam M; Soltaninejad H; Mousazadeh M; Hamidieh AA; Hosseinkhani S
Genes Dis; 2024 Jan; 11(1):268-282. PubMed ID: 37588217
[TBL] [Abstract][Full Text] [Related]
16. Nanoparticle Delivery of CRISPR/Cas9 for Genome Editing.
Duan L; Ouyang K; Xu X; Xu L; Wen C; Zhou X; Qin Z; Xu Z; Sun W; Liang Y
Front Genet; 2021; 12():673286. PubMed ID: 34054927
[TBL] [Abstract][Full Text] [Related]
17. CRISPR/Cas9 ribonucleoprotein (RNP) complex enables higher viability of transfected cells in genome editing of acute myeloid cells.
Cheng Q; Xia J; Wang K; Zhang Y; Chen Y; Zhong Q; Wang X; Wu Q
Ann Transl Med; 2022 Aug; 10(16):862. PubMed ID: 36111017
[TBL] [Abstract][Full Text] [Related]
18. A glance at genome editing with CRISPR-Cas9 technology.
Barman A; Deb B; Chakraborty S
Curr Genet; 2020 Jun; 66(3):447-462. PubMed ID: 31691023
[TBL] [Abstract][Full Text] [Related]
19. CRISPR-Cas9, A Promising Therapeutic Tool for Cancer Therapy: A Review.
Akram F; Ikram Ul Haq ; Ahmed Z; Khan H; Ali MS
Protein Pept Lett; 2020; 27(10):931-944. PubMed ID: 32264803
[TBL] [Abstract][Full Text] [Related]
20. Delivering the CRISPR/Cas9 system for engineering gene therapies: Recent cargo and delivery approaches for clinical translation.
Foley RA; Sims RA; Duggan EC; Olmedo JK; Ma R; Jonas SJ
Front Bioeng Biotechnol; 2022; 10():973326. PubMed ID: 36225598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
